DC contact with HIV-1-infected cells leads to high levels of Env-mediated virion endocytosis coupled with enhanced HIV-1 Ag presentation

European Journal of Immunology

Volumn 39, Issue 2, 2009, Pages 404-416

  Muratori, Claudia ^a   Bona, Roberta ^a   Ruggiero, Eliana ^a   D'Ettorre, Gabriella ^b   Vullo, Vincenzo ^b   Andreotti, Mauro ^a   Federico, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ag presentation; Cell to cell HIV transmission; DC; Endocytosis; HIV 1 env

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS TRANSMISSION; VIRUS VIRULENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE; VIROLOGY;

ANTIGEN PRESENTATION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENDOCYTOSIS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE;

EID: 60749089953     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838751     Document Type: Article

References (45)

1. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T. et al., Dendritic cell subsets in health and disease. Immunol. Rev. 2007. 219: 119-142.
2. Stevenson, M., HIV-1 pathogenesis. Nat. Med. 2003. 9: 853-860.
3. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P. and Steinman, R. M., HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 2004. 101: 7669-7674.
4. Smed-Sorensen, A., Lore, K., Walther-Jallow, L., Andersson, J. and Spetz, A. L., HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 2004. 104: 2810-2817.
5. Piguet, V. and Steinman, R. M., The interaction of HIV with dendritic cells: Outcomes and pathways. Trends Immunol. 2007. 28: 503-510.
6. Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W. and Steinman, R. M., Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature-cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 1998. 72: 2733-2737.
7. Turville, S. G., Cameron, P. U., Handley, A., Lin, G., Pohlmann, S., Dorms, R. W. and Cunningham, A. L., Diversity of receptors binding HIV an dendritic cell subsets. Nat. Immunol. 2002. 3: 975-983.
8. Pion, M., Granelli-Piperno, A., Mangeat, B., Stalder, R., Correa, R., Steinman, R. M. and Piguet, V., APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 2006. 203: 2887-2893.
9. Turville, S. G., Santos, J. J., Frank, I., Cameron, P. U., Wilkinson, J., Miranda-Saksena, M., Dable, J. et al., Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004. 103: 2170-2179.
10. Moris, A., Pajot, A., Blanchet, F., Guivel-Benhassine, F., Salcedo, M. and Schwartz, O., Dendritic cells and HIV-specific CD4+T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 2006. 108: 1643-1651.
11. Buseyne, F., Le, G. S., Boccaccio, C., Abastado, J. P., Lifson, J. D., Arthur, L. O., Riviere, Y. et al., MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 2001. 7: 344-349.
12. Moris, A., Nobile, C., Buseyne, F., Porrot, F., Abastado, J. P. and Schwartz, O., DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 2004. 103: 2648-2654.
13. Sabado, R. L., Babcock, E., Kavanagh, D. G., Tjomsland, V., Walker, B. D., Lifson, J. D., Bhardwaj, N. and Larsson, M., Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1. Eur. J. Immunol. 2007. 37: 1752-1763.
14. Marsac, D., Loirat, D., Petit, C., Schwartz, O. and Michel, M. L., Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type I (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseuclotyped HIV-1 Gag particles. J. Virol. 2002. 76: 7544-7553.
15. Geijtenbeek, T. B., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Middel, J., Cornelissen, I. L. et al., DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000. 100: 587-597.
16. Carr, J. M., Hocking, H., Li, P. and Burrell, C. J., Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 1999. 265: 319-329.
17. Jolly, C., Kashefi, K., Hollinshead, M. and Sattentau, Q. J., HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 2004. 199: 283-293.
18. Ruggiero, E., Bona, R., Muratori, C. and Federico, M., Virological consequences of early events following the cell-cell contact between HIV-1, infected and uninfected CD4+ Cells. J. Virol. 2008. 82: 7773-7789.
19. KiIby, J. M., Hopkins, S., Venetta, T. M., Di Massimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L. et al., Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 1998. 4: 1302-1307.
20. Wang, J. H., Janas, A. M., Olson, W. J. and Wu, L., Functionally distinct: Transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J. Virol. 2007. 81: 8933-8943.
21. Olivetta, E., Pugliese, K., Bona, R., D'Aloja, P., Ferrantelli, F., Santarcangelo, A. C., Mattia, G. et al., cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails. J. Virol. 2000. 74: 483-492.
22. Schaeffer, E., Geleziunas, R. and Greene, W. C., Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 2001. 75: 2993-3000.
23. Schaeffer, E., Soros, V. B. and Greene, W. C., Compensatory link between fusion and endocytotis of human immunodeficiency virus type 1 in human CD41T lymphocytes. J. Virol. 2004. 78: 1375-1383.
24. de Witte, L., Nabatov, A., Pion, M., Fluitsma, D., de Jong, M.A., de, G. T., Piguet, V. et al., Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007. 13: 367-371.
25. Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N. et al., Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 2003. 77: 2081-2092.
26. Frahm, N., Korber, B. T., Adams, C. M., Szinger, J. J., Draenert, R., Addo, M. M., Feeney, M. E. et al., Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple edinicities. J. Virol. 2004. 78: 2187-2200.
27. Peretz, Y., Alter, G., Boisvert, M. P., Hatzakis, G., Tsoukas, C. M. and Bernard, N. F., Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. J. Virol. 2005. 79: 4908-4917.
28. Coplan, P. M., Gupta, S. B., Dubey, S. A., Pitisuttithum, P., Nikas, A., Mbewe, B., Vardas, E. et al., Cross-reactivity of anti-HIV-1IT cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J. Infect. Dis. 2005. 191: 1427-1434.
29. Hodges, A., Sharrocks, K., Edelmann, M., Baban, D., Moris, A., Schwartz, O., Drakesmith, H. et al., Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 2007. 8: 569-577.
30. de Witte, L., Bobardt, M., Chatterji, U., Degeest, G., David, G., Geijtenbeek, T. B. and GaIlay, P., Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. USA 2007. 104: 19464-19469.
31. McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D. and Hope, T. J., Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003. 300: 1295-1297.
32. Arrighi, J. F., Pion, M., Garcia, E., Escola, J. M., van, K. Y., Geijtenbeek, T. B. and Piguet, V., DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 2004. 200: 1279-1288.
33. Maranon, C., Desoutter, J. F., Hoeffel, G., Cohen, W., Hanau, D. and Hosmalin, A., Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+T lymphocytes. Proc. Natl. Acad. Sci. USA 2004. 101: 6092-6097
34. Bomsel, M. and Alfsen, A., Entry of viruses through the epithelial barrier: Pathogenic trickery. Nat. Rev. Mol. Cell Biol. 2003. 4: 57-68.
35. Hladik, F., Sakchalathom, P., Ballweber, L., Lentz, G., Fialkow, M., Eschenbach, D. and McElrath, M. J., Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007. 26: 257-270.
36. Haase, A. T., Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 2005. 5: 783-792.
37. Dandekar, S., Pathogenesis of HIV in the gastrointestinal tract. Curr. HIV/AIDS Rep. 2007. 4: 10-15.
38. Demoustier, A., Gubler, B., Lambotte, O., de Goer, M. G., Wallon, C., Goujard, C., Delfraissy, J. F. and Taoufik, Y., In patients on prolonged HAART, a significant pool of HIV infected CD41T cells are HIV-specific. AIDS 2002. 16: 1749-1754.
39. Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P. et al., HIV preferentially infects HIV-specific CD4+T cells. Nature 2002. 417: 95-98.
40. Harari, A., Rizzardi, G. P., Ellefsen, K., Ciuffreda, D., Champagpagne, P., Bart, P. A., Kaufmann, D. et al., Analysis of HIV-1 and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002. 100: 1381-1387.
41. Koren, H. S., Anderson, S. J. and Larrick, J. W., In vitro activation of a human macrophage-like cell line. Nature 1979. 279: 328-331.
42. Muratori, C., Sistigu, A., Ruggiero, E., Falchi, M., Bacigalupo, I., Palladino, C., Toschi, E. and Federico, M., Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J. Virol. 2007. 81: 9078-9087.
43. Sparacio, S., Pfeiffer, T., Schaal, H. and Bosch, V., Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Mol. Ther. 2001. 3: 602-612.
44. Federico, M., Percario, Z., Olivetta, E., Fiorucci, G., Muratori, C., Micheli, A., Romeo, G. and Affabris, E., HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 2001. 98: 2752-2761.
45. Muratori, C., D'Aloja, P., Superti, F., Tinari, A., Sol-Foulon, N., Sparacio, S., Bosch, V. et al., Generation and characterization of a stable cell population releasing fluorescent HIV-1-based virus like particles in an inducible way. BMC Biotechnol. 2006. 6: 52.